Skip Navigation Links.

Fresenius Kabi Oncology Ltd


BSE: 532545 | NSE: FKONCO | ISIN: INE575G01010 
Market Cap: [Rs.Cr.] 1,977 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Multinational

 Discuss this stock

Key Executives

Chairman Rakesh Bhargava
Director Dilip G Shah
Director Gerrit Steen
Director Michael Schonhofen

Peer Comparison

Company Market Cap
(Rs. in Cr.) 		P/E (TTM)
(x) 		P/BV (TTM)
(x) 		EV/EBIDTA
(x) 		ROE
(%) 		ROCE
(%) 		D/E
(x)
Glaxosmit Pharma 19,207.00 29.02 9.56 18.86 34.3 45.2 0.00
Sanofi India 5,688.41 31.44 4.77 13.73 15.4 22.5 0.00
Pfizer 3,126.19 15.17 1.83 9.41 15.0 22.1 0.00
Abbott India 3,070.09 18.49 4.75 12.08 24.3 34.8 0.00
Fres.Kabi Onco. 1,976.71 22.04 3.34 22.38 3.5 5.4 0.42
Wyeth 1,771.48 13.62 3.09 7.61 33.4 45.1 0.01
Astrazeneca Phar 1,729.88 0.00 17.34 140.28 10.7 15.2 0.03
Novartis India 1,597.68 13.34 1.77 10.43 20.0 28.8 0.00
Merck 1,079.08 13.49 2.23 7.04 17.5 25.5 0.00
Fulford (India) 247.65 0.00 1.71 0.00 -3.4 -4.7 0.00
Organon (India) 159.14 0.00 0.98 0.00 15.3 22.8 0.00

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Rakesh Bhargava , Chairman 

Dilip G Shah , Director 

Gerrit Steen , Director 

Michael Schonhofen , Director 

Company Head Office / Quarters:
B-310 Som Datt Chambers-I,
Bhikaji Cama Place,
New Delhi,
New Delhi-110066
Phone : 91-11-26105570
Fax : 91-11-26195965
E-mail : complianceofficer.india@fresenius-kabi.com
Web : http://www.fresenius-kabi-oncology.com
Registrars:
MCS Ltd
F-65 1st Floor
Okhla Industrial Are
Phase-I
New Delhi-110020

Fund Holding

 

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Open : India Finsec
Economic Events
list No economic event today
Results
list Bharat Forge | Oil India | Container Corpn.